The effects of exercise on cognition in Parkinson's disease: A systematic review

Translational Neurodegeneration

Volumn 3, Issue 1, 2014, Pages

  Murray, Danielle K ^a   Sacheli, Matthew A ^a   Eng, Janice J ^a   Stoessl, A J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Animals; Cognition; Exercise; Humans; Parkinson's disease

Indexed keywords

AEROBIC EXERCISE; BASAL GANGLION; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DANCE THERAPY; DISEASE MODEL; EVIDENCE BASED MEDICINE; EXECUTIVE FUNCTION; HUMAN; KINESIOTHERAPY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUBLISHING; RESISTANCE TRAINING; REVIEW; SYSTEMATIC REVIEW;

EID: 84896695614     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-3-5     Document Type: Review

References (57)

1. Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, Cummings JL. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999, 67:492-496. 10.1136/jnnp.67.4.492, 1736593, 10486397.
2. Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006, 5:235-245. 10.1016/S1474-4422(06)70373-8, 16488379.
3. Macht M, Schwarz R, Ellgring H. Patterns of psychological problems in Parkinson's disease. Acta neurologica Scandinavica 2005, 111:95-101. 10.1111/j.1600-0404.2005.00375.x, 15644068.
4. Hely MA, Reid WGJ, Adena MA, Halliday GA, Morris JGL. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008, 23:837-844. 10.1002/mds.21956, 18307261.
5. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53:695-699. 10.1111/j.1532-5415.2005.53221.x, 15817019.
6. Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RMA, Wadia P, Miyasaki J, Duff-Canning S, Lang AE, Marras C. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord 2008, 23:297-299. 10.1002/mds.21837, 18044697.
7. Muller T, Kuhn W. Cysteine elevation in levodopa-treated patients with Parkinson's disease. Mov Disord 2009, 24:929-932. 10.1002/mds.22482, 19243072.
8. Tillerson JL, Caudle WM, Reveron ME, Miller GW. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience 2003, 119:899-911. 10.1016/S0306-4522(03)00096-4, 12809709.
9. Allen NE, Sherrington C, Paul SS, Canning CG. Balance and falls in Parkinson's disease: a meta-analysis of the effect of exercise and motor training. Mov Disord 2011, 26:1605-1615. 10.1002/mds.23790, 21674624.
10. Lauhoff P, Murphy N, Doherty C, Horgan NF. A controlled clinical trial investigating the effects of cycle ergometry training on exercise tolerance, balance and quality of life in patients with Parkinson's disease. Disabil Rehabil 2013, 35:382-387. 10.3109/09638288.2012.694962, 22747197.
11. Ridgel AL, Peacock CA, Fickes EJ, Kim CH. Active-assisted cycling improves Tremor and Bradykinesia in Parkinson's disease. Arch Phys Med Rehabil 2049-2054, 2012:93.
12. Ridgel AL, Vitek JL, Alberts JL. Forced, not voluntary, exercise improves motor function in Parkinson's disease patients. Neurorehabil Neural Repair 2009, 23:600-608. 10.1177/1545968308328726, 19131578.
13. Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease?. Neurology 2011, 77:288-294. 10.1212/WNL.0b013e318225ab66, 3136051, 21768599.
14. Hindle JV, Petrelli A, Clare L, Kalbe E. Nonpharmacological enhancement of cognitive function in Parkinson's disease: a systematic review. Mov Disord 2013, 28:1034-1049. 10.1002/mds.25377, 23426759.
15. Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Plos Med 2009, 6:e1000097. 10.1371/journal.pmed.1000097, 2707599, 19621072.
16. Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- lesioned mouse basal ganglia. J Neurosci Res 2004, 77:378-390. 10.1002/jnr.20162, 15248294.
17. Gorton LM, Vuckovic MG, Vertelkina N, Petzinger GM, Jakowec MW, Wood RI. Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse. Behav Brain Res 2010, 213:253-262. 10.1016/j.bbr.2010.05.009, 2902645, 20472000.
18. Tajiri N, Yasuhara T, Shingo T, Kondo A, Yuan W, Kadota T, Wang F, Baba T, Tayra JT, Morimoto T, Jing M, Kikuchi Y, Kuramoto S, Agari T, Miyoshi Y, Fujino H, Obata F, Takeda I, Furuta T, Date I. Exercise exerts neuroprotective effects on Parkinson's disease model of rats. Brain Res 2010, 1310:200-207.
19. Aguiar AS, Araujo AL, Da-Cunha TR, Speck AE, Ignacio ZM, De-Mello N, Prediger RD. Physical exercise improves motor and short-term social memory deficits in reserpinized rats. Brain Res Bull 2009, 79:452-457. 10.1016/j.brainresbull.2009.05.005, 19463920.
20. Pothakos K, Kurz MJ, Lau Y-S. Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration. Bmc Neuroscience 2009, 10:6. 10.1186/1471-2202-10-6, 2640401, 19154608.
21. Goes AT, Souza LC, Filho CB, Del Fabbro L, De Gomes MG, Boeira SP, Jesse CR. Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine. Neuroscience 2014, 256:61-71.
22. Baatile J, Langbein WE, Weaver F, Maloney C, Jost MB. Effect of exercise on perceived quality of life of individuals with Parkinson's disease. J Rehabil Res Dev 2000, 37:529-534.
23. Muller T, Muhlack S. Effect of exercise on reactivity and motor behaviour in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2010, 81:747-753. 10.1136/jnnp.2009.174987, 20478845.
24. Pompeu JE, dos Santos Mendes FA, da Silva KG, Lobo AM, Oliveira TP, Zomignani AP, Pimentel Piemonte ME. Effect of Nintendo Wii (TM)-based motor and cognitive training on activities of daily living in patients with Parkinson's disease: a randomised clinical trial. Physiotherapy 2012, 98:196-204. 10.1016/j.physio.2012.06.004, 22898575.
25. dos Santos Mendes FA, Pompeu JE, Modenesi Lobo A, Guedes Da Silva K, Oliveira Tde P, Peterson Zomignani A, Pimentel Piemonte ME. Motor learning, retention and transfer after virtual-reality-based training in Parkinson's disease-effect of motor and cognitive demands of games: a longitudinal, controlled clinical study. Physiotherapy 2012, 98:217-223. 10.1016/j.physio.2012.06.001, 22898578.
26. Cruise KE, Bucks RS, Loftus AM, Newton RU, Pegoraro R, Thomas MG. Exercise and Parkinson's: benefits for cognition and quality of life. Acta neurologica Scandinavica 2011, 123:13-19. 10.1111/j.1600-0404.2010.01338.x, 20199518.
27. Tanaka K, Quadros AC, Santos RF, Stella F, Gobbi LT, Gobbi S. Benefits of physical exercise on executive functions in older people with Parkinson's disease. Brain Cogn 2009, 69:435-441. 10.1016/j.bandc.2008.09.008, 19006643.
28. Ridgel AL, Kim C-H, Fickes EJ, Muller MD, Alberts JL. Changes in executive function after acute bouts of passive cycling in Parkinson's disease. J Aging Phys Act 2011, 19:87-98.
29. McKee K, Hackney ME. The effects of adapted tango on spatial cognition and disease severity in Parkinson's disease. J Mot Behav 2013, 45:519-529. 10.1080/00222895.2013.834288, 24116748.
30. Goes AT, Souza LC, Filho CB, Del Fabbro L, De Gomes MG, Boeira SP, Jesse CR. Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine. Neuroscience 2013, 256C:61-71.
31. Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Neurobiol Dis 2012, 45:1051-1067. 10.1016/j.nbd.2011.12.024, 22198503.
32. Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Brit Med J 2011, 343:889-893.
33. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.9 [updated March 2011]. The Cochrane Collaboration 2011, Higgins JPT, Green S, Available from http://www.cochrane-handbook.org.
34. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442. 10.1212/WNL.17.5.427, 6067254.
35. Gerlach M, Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 1996, 103:987-1041. 10.1007/BF01291788, 9013391.
36. Jakowec MW, Petzinger GM. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of Parkinson's disease, with emphasis on mice and nonhuman primates. Comparative Med 2004, 54:497-513.
37. Colpaert FC. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacology 1987, 26:1431-1440. 10.1016/0028-3908(87)90110-9, 3670563.
38. Schwarting RK, Huston JP. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Progress in neurobiology 1996, 50:275-331. 10.1016/S0301-0082(96)00040-8, 8971983.
39. Schwarting RK, Huston JP. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Progress in neurobiology 1996, 49:215-266. 10.1016/S0301-0082(96)00015-9, 8878304.
40. Schwarting RK, Huston JP. Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions. Neurotoxicology 1997, 18:689-708.
41. Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VMY. Pathological alpha-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice. Science 2012, 338:949-953. 10.1126/science.1227157, 3552321, 23161999.
42. Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kovari E. Neuropathology of dementia in a large cohort of patients with Parkinson's disease. Parkinsonism Relat Disord 2013, 19:864-868. discussion 864, 10.1016/j.parkreldis.2013.05.010, 23746454.
43. Kim S-E, Ko I-G, Shin M-S, Kim C-J, Jin B-K, Hong H-P, Jee Y-S. Treadmill exercise and wheel exercise enhance expressions of neutrophic factors in the hippocampus of lipopolysaccharide-injected rats. Neurosci Lett 2013, 538:54-59.
44. Zigmond MJ, Cameron JL, Hoffer BJ, Smeyne RJ. Neurorestoration by physical exercise: moving forward. Parkinsonism Relat Disord 2012, 18(Supplement 1):S147-S150.
45. Fisher BE, Li Q, Nacca A, Salem GJ, Song J, Yip J, Hui JS, Jakowec MW, Petzinger GM. Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson's disease. Neuroreport 2013, 24:509-514. 10.1097/WNR.0b013e328361dc13, 23636255.
46. Higginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA. The relationship between executive function and verbal memory in Parkinson's disease. Brain Cogn 2003, 52:343-352. 10.1016/S0278-2626(03)00180-5, 12907179.
47. Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rogriguez-Oroz MC, Burn DJ, Barker RA, Emre M. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012, 27:349-356. 10.1002/mds.24893, 3641655, 22275317.
48. Kudlicka A, Clare L, Hindle JV. Executive functions in Parkinson's disease: Systematic review and meta-analysis. Mov Disord 2011, 26:2305-2315. 10.1002/mds.23868, 21971697.
49. Lezak MD. Neuropsychological assessment 1995, New York: Oxford University Press, 3.
50. Kramer AF, Hahn S, Cohen NJ, Banich MT, McAuley E, Harrison CR, Chason J, Vakil E, Bardell L, Boileau RA, Colcombe A. Ageing, fitness and neurocognitive function. Nature 1999, 400:418-419. 10.1038/22682, 10440369.
51. Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P, Turnquist P, Vuckovic M, Fisher BE, Togasaki DM, Jakowec MW. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci 2007, 27:5291-5300. 10.1523/JNEUROSCI.1069-07.2007, 17507552.
52. Vuckovic MG, Li QZ, Fisher B, Nacca A, Leahy RM, Walsh JP, Mukherjee J, Williams C, Jakowec MW, Petzinger GM. Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: in Vivo imaging with [F-18]Fallypride. Mov Disord 2010, 25:2777-2784. 10.1002/mds.23407, 3273304, 20960487.
53. de Melo Coelho FG, Gobbi S, Almeida Andreatto CA, Corazza DI, Pedroso RV, Santos-Galduroz RF. Physical exercise modulates peripheral levels of brain-derived neurotrophic factor (BDNF): a systematic review of experimental studies in the elderly. Arch Gerontol Geriatr 2013, 56:10-15. 10.1016/j.archger.2012.06.003, 22749404.
54. Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, Danker-Hopfe H, Gass P. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 2009, 42:270-276. 10.1055/s-0029-1224162, 19924587.
55. Chang YK, Labban JD, Gapin JI, Etnier JL. The effects of acute exercise on cognitive performance: a meta-analysis. Brain Res 2012, 1453:87-101.
56. Langlois F, Vu TTM, Chasse K, Dupuis G, Kergoat MJ, Bherer L. Benefits of physical exercise training on cognition and quality of life in frail older adults. J Gerontol B-Psychol 2013, 68:400-404.
57. Gates N, Fiatarone Singh MA, Sachdev PS, Valenzuela M. The effect of exercise training on cognitive function in older adults with mild cognitive impairment: a meta-analysis of randomized controlled trials. Am J Geriatr Psychiatry 2013, 21:1086-1097. 10.1016/j.jagp.2013.02.018, 23831175.